Seeking Alpha

Premarket gainers: NPSP +11%. CTIC +9%. STM +8%.Losers: AEZS -24%. AMD -11%. INFY -7%.

Premarket gainers: NPSP +11%. CTIC +9%. STM +8%.
Losers: AEZS -24%. AMD -11%. INFY -7%.
Comments (1)
  • Capitalization: 108,835,924

     

    TOTAL CURRENT 91,868,839 ACTIONS
    AFTER the CONVERSION of the REMAINING PREFERENCE SHARES equivalent to 18,400 13,156,000 ORDINARY SHARES, the TOTAL NUMBER of SHARES would be 105,024,839 which, at CURRENT PRICE of 1,187€ COMPORTEREBE
    A capitalization of 124,664,448 €.
    CONSIDERING a CASE about (19.000.0 + 56,000,000) $ = $ 75,000,000 EQUAL APPROXIMATELY to 57,692,000 €
    CAPITALIZATION-DEDUCTING that AMOUNT FROM the VALUE of the company would be $ 66,972,448.
    According to the last there would be about 8,000 patients a year interested in spending Pixuvri average of 28,000 € each for a total amount of $ 224,000,000.
    Assuming a 50% of expenditure for the production for marketing you should have an annual return of $ 112,000,000.Leaving aside some cash for Opaxio-orphan-drug in the u.s., may be compounding so low?.
    18 Oct 2012, 08:56 AM Reply Like
DJIA (DIA) S&P 500 (SPY)